FDA Inspection 1301536 — Ethypharm
The FDA completed an inspection of Ethypharm on Oct 7, 2022 in Le Grand Quevilly CEDEX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 7, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Le Grand Quevilly CEDEX (France)
Additional details
Mutual Recognition Agreement (MRA)